Immunology/Inflammation
Immunology/Inflammation(免疫及炎症)
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
- 5-Lipoxygenase(11)
- Papain(1)
- PGDS(1)
- PGE synthase(24)
- SIKs(12)
- IκB/IKK(67)
- AP-1(6)
- KEAP1-Nrf2(65)
- NOD1(1)
- TLR(140)
- NF-κB(241)
- Interleukin Related(171)
- 15-lipoxygenase(2)
- Others(63)
- Aryl Hydrocarbon Receptor(36)
- CD73(14)
- Complement System(58)
- Galectin(12)
- IFNAR(25)
- NO Synthase(77)
- NOD-like Receptor (NLR)(51)
- STING(110)
- Reactive Oxygen Species(465)
- Apoptosis(802)
- FKBP(20)
- eNOS(5)
- iNOS(29)
- nNOS(20)
- Glutathione(57)
- Adaptive Immunity(222)
- Allergy(130)
- Arthritis(34)
- Autoimmunity(190)
- Gastric Disease(101)
- Immunosuppressants(39)
- Immunotherapeutics(5)
- Innate Immunity(593)
- Pulmonary Diseases(119)
- Reactive Nitrogen Species(55)
- Reactive Sulfur Species(28)
- Specialized Pro-Resolving Mediators(50)
- Cyclic GMP-AMP Synthase(2)
- BCL6(3)
- CD20(3)
- CD22
- CD28(1)
- FAP(7)
- PSMA(7)
- Nuclear Factor of activated T Cells (NFAT)(1)
- Glycoprotein VI(1)
- Tim3(2)
- Hapten(1)
- Nectin-4(2)
Immunology/Inflammation 相关产品(4245)
- GC12370IKK-16 (hydrochloride)CAS: 1186195-62-9
IKK-16 (hydrochloride)是一种新型的、具有口服活性的选择性IκB激酶(IKK)抑制剂,IKK-16作用于IKK-2、IKK复合物和IKK-1的IC 50 值分别为40nM、70nM和200nM
- GC12520Diphenyleneiodonium chlorideCAS: 4673-26-1纯度: >99.50%
二苯碘铵 (DPI) 氯化物 (DPIC) 作为 NADH/NADPH 氧化酶抑制剂,对 Mtb 和 S. aureus 具有有效的抗菌活性。
- GC12544Hydroxychloroquine SulfateCAS: 747-36-4纯度: >99.50%
Hydroxychloroquine Sulfate是一种合成的4-氨基喹啉衍生物类抗疟药。
- GC12555GS-9620 (Vesatolimod)CAS: 1228585-88-3纯度: >99.50%
GS-9620 (Vesatolimod)是一种具口服活性的有效的Toll样受体7(TLR7)激动剂,EC 50 值为291nM,具有抗病毒作用。
- GC12578(R)-LisofyllineCAS: 100324-81-0纯度: >97.00% / >98.00%
(R)-Lisofylline一种具有抗炎特性的小分子化合物,作为一种溶血磷脂酸酰基转移酶抑制剂(IC₅₀=0.6μM)。
- GC12867L-NIO dihydrochlorideCAS: 159190-44-0
L-NIO dihydrochloride 是一种有效、非选择性和 NADPH 依赖性一氧化氮合酶 (NOS) 抑制剂,对神经元 (nNOS)、内皮细胞 (eNOS) 和诱导型 (iNOS) 的 Kis 分别为 1.7、3.9、3.9 μM 。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC12277 | MK 886 | 118414-82-7 | >99.50% | |
A potent, selective inhibitor of FLAP | ||||
| GC12288 | GSK-J1 sodium salt | 1797832-71-3 | - | |
A dual inhibitor of JMJD3 and UTX | ||||
| GC12309 | 7-Nitroindazole | 2942-42-9 | - | |
A non-selective inhibitor of NOS isoforms | ||||
| GC12325 | BYK 191023 dihydrochloride | 1216722-25-6 | - | |
A selective iNOS inhibitor | ||||
| GC12330 | SAR191801 | 1234708-04-3 | >99.50% | |
SAR191801 是一种 hPGDS 抑制剂,在荧光偏振试验或 EIA 试验中的 IC50 为 12 nM。 | ||||
| GC12331 | JC-1 | 3520-43-2 | >99.00% / >98.00% / >95.00% | |
JC-1(CBIC2) is a cationic carbonyl cyanine fluorescent dye. | ||||
| GC12342 | NDT 9513727 | 439571-48-9 | >99.00% | |
A competitive antagonist of the C5a receptor | ||||
| GC12367 | CM-272 | 1846570-31-7 | >98.00% | |
An inhibitor of G9a, GLP, and DNA methyltransferases | ||||
| GC12370 | IKK-16 (hydrochloride) | 1186195-62-9 | - | |
IKK-16 (hydrochloride)是一种新型的、具有口服活性的选择性IκB激酶(IKK)抑制剂,IKK-16作用于IKK-2、IKK复合物和IKK-1的IC 50 值分别为40nM、70nM和200nM | ||||
| GC12399 | BMS345541 hydrochloride | 547757-23-3 | >99.50% | |
A selective inhibitor of IKKα and IKKβ | ||||
| GC12517 | Sasapyrine | 552-94-3 | >98.00% | |
An NSAID and a prodrug form of salicylic acid | ||||
| GC12520 | Diphenyleneiodonium chloride | 4673-26-1 | >99.50% | |
二苯碘铵 (DPI) 氯化物 (DPIC) 作为 NADH/NADPH 氧化酶抑制剂,对 Mtb 和 S. aureus 具有有效的抗菌活性。 | ||||
| GC12532 | CHPG | 170846-74-9 | >98.00% | |
A potent and selective mGluR5 agonist | ||||
| GC12537 | ATB-337 | 912758-00-0 | - | |
A hydrogen sulfide-releasing NSAID | ||||
| GC12544 | Hydroxychloroquine Sulfate | 747-36-4 | >99.50% | |
Hydroxychloroquine Sulfate是一种合成的4-氨基喹啉衍生物类抗疟药。 | ||||
| GC12555 | GS-9620 (Vesatolimod) | 1228585-88-3 | >99.50% | |
GS-9620 (Vesatolimod)是一种具口服活性的有效的Toll样受体7(TLR7)激动剂,EC 50 值为291nM,具有抗病毒作用。 | ||||
| GC12567 | TRIM | 25371-96-4 | - | |
An inhibitor of nNOS and iNOS | ||||
| GC12578 | (R)-Lisofylline | 100324-81-0 | >97.00% / >98.00% | |
(R)-Lisofylline一种具有抗炎特性的小分子化合物,作为一种溶血磷脂酸酰基转移酶抑制剂(IC₅₀=0.6μM)。 | ||||
| GC12604 | Fumonisin B1 | 116355-83-0 | >98.00% / >95.00% | |
A mycotoxin | ||||
| GC12609 | PS 1145 dihydrochloride | 1049743-58-9 | - | |
An IKKβ inhibitor | ||||
| GC12628 | ITE | 448906-42-1 | >99.00% | |
ITE是一种有效的免疫抑制性内源性芳香烃受体(AhR)激动剂,与AhR结合的K i 值为3nM。 | ||||
| GC12677 | N-Benzylacetamidine (hydrobromide) | 186545-76-6 | - | |
Potent, selective inhibitor of iNOS | ||||
| GC12821 | Oltipraz | 64224-21-1 | >99.50% | |
A Nrf2 and CAR activator | ||||
| GC12867 | L-NIO dihydrochloride | 159190-44-0 | - | |
L-NIO dihydrochloride 是一种有效、非选择性和 NADPH 依赖性一氧化氮合酶 (NOS) 抑制剂,对神经元 (nNOS)、内皮细胞 (eNOS) 和诱导型 (iNOS) 的 Kis 分别为 1.7、3.9、3.9 μM 。 | ||||
